Literature DB >> 15308688

C-terminal domain of insulin-like growth factor (IGF) binding protein-6: structure and interaction with IGF-II.

Stephen J Headey1, David W Keizer, Shenggen Yao, Geoffrey Brasier, Phillip Kantharidis, Leon A Bach, Raymond S Norton.   

Abstract

IGFs are important mediators of growth. IGF binding proteins (IGFBPs) 1-6 regulate IGF actions and have IGF-independent actions. The C-terminal domains of IGFBPs contribute to high-affinity IGF binding and modulation of IGF actions and confer some IGF-independent properties, but understanding how they achieve this has been constrained by the lack of a three-dimensional structure. We therefore determined the solution structure of the C-domain of IGFBP-6 using nuclear magnetic resonance (NMR). The domain consists of a thyroglobulin type 1 fold comprising an alpha-helix followed by a loop, a three-stranded antiparallel beta-sheet incorporating a second loop, and finally a disulfide-bonded flexible third loop. The IGF-II binding site on the C-domain was identified by examining NMR spectral changes upon complex formation. It consists of a largely hydrophobic surface patch involving the alpha-helix, the first beta-strand, and the first and second loops. The site was confirmed by mutagenesis of several residues, which resulted in decreased IGF binding affinity. The IGF-II binding site lies adjacent to surfaces likely to be involved in glycosaminoglycan binding of IGFBPs, which might explain their decreased IGF affinity when bound to glycosaminoglycans, and nuclear localization. Our structure provides a framework for understanding the roles of IGFBP C-domains in modulating IGF actions and conferring IGF-independent actions, as well as ultimately for the development of therapeutic IGF inhibitors for diseases including cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15308688     DOI: 10.1210/me.2004-0248

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  11 in total

1.  Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins.

Authors:  Tomasz Sitar; Grzegorz M Popowicz; Igor Siwanowicz; Robert Huber; Tad A Holak
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-21       Impact factor: 11.205

2.  Functional anthology of intrinsic disorder. 3. Ligands, post-translational modifications, and diseases associated with intrinsically disordered proteins.

Authors:  Hongbo Xie; Slobodan Vucetic; Lilia M Iakoucheva; Christopher J Oldfield; A Keith Dunker; Zoran Obradovic; Vladimir N Uversky
Journal:  J Proteome Res       Date:  2007-03-29       Impact factor: 4.466

3.  Expression, crystallization and preliminary X-ray characterization of the human epithelial cell-adhesion molecule ectodomain.

Authors:  Miha Pavšič; Brigita Lenarčič
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-10-27

4.  Recent insights into the actions of IGFBP-6.

Authors:  Leon A Bach
Journal:  J Cell Commun Signal       Date:  2015-03-26       Impact factor: 5.782

Review 5.  Thyroglobulin From Molecular and Cellular Biology to Clinical Endocrinology.

Authors:  Bruno Di Jeso; Peter Arvan
Journal:  Endocr Rev       Date:  2015-11-23       Impact factor: 19.871

6.  Prediction of the rotational tumbling time for proteins with disordered segments.

Authors:  Sung-Hun Bae; H Jane Dyson; Peter E Wright
Journal:  J Am Chem Soc       Date:  2009-05-20       Impact factor: 15.419

7.  Serine 204 phosphorylation and O-β-GlcNAC interplay of IGFBP-6 as therapeutic indicator to regulate IGF-II functions in viral mediated hepatocellular carcinoma.

Authors:  Waqar Ahmad; Khadija Shabbiri; Bushra Ijaz; Sultan Asad; Noreen Nazar; Shazia Nazar; Kiran Fouzia; Humera Kausar; Sana Gull; Muhammad T Sarwar; Imaran Shahid; Sajida Hassan
Journal:  Virol J       Date:  2011-05-08       Impact factor: 4.099

8.  Insulin-like growth factor binding proteins: a structural perspective.

Authors:  Briony E Forbes; Peter McCarthy; Raymond S Norton
Journal:  Front Endocrinol (Lausanne)       Date:  2012-03-02       Impact factor: 5.555

9.  A holistic approach to dissecting SPARC family protein complexity reveals FSTL-1 as an inhibitor of pancreatic cancer cell growth.

Authors:  Katrina Viloria; Amanda Munasinghe; Sharan Asher; Roberto Bogyere; Lucy Jones; Natasha J Hill
Journal:  Sci Rep       Date:  2016-11-25       Impact factor: 4.379

Review 10.  Mechanisms Applied by Protein Inhibitors to Inhibit Cysteine Proteases.

Authors:  Livija Tušar; Aleksandra Usenik; Boris Turk; Dušan Turk
Journal:  Int J Mol Sci       Date:  2021-01-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.